HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of lung adenocarcinoma with coexisting G719X and T790M EGFR mutations in which erlotinib was effective for the treatment of leptomeningeal carcinomatosis].

Abstract
A 68-year-old man was referred to our hospital because of an abnormal chest shadow. Adenocarcinoma was detected using percutaneous needle aspiration cytology from the left supraclavicular lymph node. The patient was diagnosed as having primary adenocarcinoma of the lung(cT1bN3M1b: BRA OSS). Exon 18G 719X and exon 20 T790M mutations of the EGFR gene were detected in the same specimen. For first-line chemotherapy, four courses of cisplatin plus docetaxel were used. The primary lesion and a brain metastasis were reduced after the first-line chemotherapy. About four months later, he developed a recurrent brain metastasis and leptomeningeal carcinomatosis. He was treated with erlotinib(150mg/day)after wholebrain irradiation. The leptomeningeal carcinomatosis findings on a head CT image and the patient's consciousness disorder improved after treatment. EGFR-TKI therapy was effective in a case with leptomeningeal carcinomatosis, and coexisting EGFRsensitive and EGFR-resistant mutations.
AuthorsKen Katono, Masashi Kasajima, Mikiko Ishihara, Nobuatsu Hayashi, Yujiro Nagashima, Satoshi Igawa, Noriyuki Masuda
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 40 Issue 3 Pg. 375-7 (Mar 2013) ISSN: 0385-0684 [Print] Japan
PMID23507602 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
Topics
  • Adenocarcinoma (drug therapy, genetics, pathology)
  • Adenocarcinoma of Lung
  • Aged
  • Biopsy
  • Brain Neoplasms (drug therapy, genetics, secondary)
  • Erlotinib Hydrochloride
  • Humans
  • Lung Neoplasms (drug therapy, genetics, pathology)
  • Male
  • Meningeal Carcinomatosis (drug therapy, genetics, secondary)
  • Mutation
  • Protein Kinase Inhibitors (therapeutic use)
  • Quinazolines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: